3D Protein Structure Analysis Market by Component, Technique, End-User

Description

List of Tables

[186 Pages Report] The 3D Protein Structure Analysis Market size was estimated at USD 1.25 billion in 2023 and expected to reach USD 1.38 billion in 2024, at a CAGR 10.04% to reach USD 2.45 billion by 2030.

Global 3D Protein Structure Analysis Market

KEY MARKET STATISTICS
Base Year [2023]	USD 1.25 billion
Estimated Year [2024]	USD 1.38 billion
Forecast Year [2030]	USD 2.45 billion
CAGR (%)	10.04%

3D Protein Structure Analysis Market - IMG1

The market for 3D protein structure analysis comprises the range of products, services, and solutions used in determining the three-dimensional arrangement of atoms within a protein molecule. These solutions aid researchers and professionals in the field of biochemistry, molecular biology, pharmacology, and biotechnology to comprehend protein function, interaction, and the overall mechanism within biological processes. The primary applications of 3D protein structure analysis include drug discovery and design, protein function analysis, and understanding disease mechanisms. Key end-users revolutionizing the field encompass academic research institutions, pharmaceutical and biotechnological companies, and contract research organizations (CROs). Market scope expands with increased investments in research and development activities and a surge in demand for new drug discovery fueled by the growing prevalence of chronic diseases. The advancement of computational power and bioinformatics tools has further broadened the scope of the market. Growth drivers include technological advancements in protein structure analysis methods, rising investment in research and development by biopharmaceutical companies, and the growing number of interdisciplinary collaborations between academic institutions and the private sector. Moreover, the increased focus on personalized medicine and structural biology plays a crucial role in propelling the market forward. New opportunities in the 3D protein structure analysis stem from the adoption of artificial intelligence and machine learning in protein structure prediction and analysis. Additionally, the expansion into untapped markets in developing countries and the application of 3D protein models in the study of emerging diseases like COVID-19 offer potential growth avenues.

Regional Insights

The United States stands at the forefront of the 3D protein structure analysis market, benefiting from a strong infrastructure for biotechnological research, substantial investment from both public and private sectors, and a vibrant ecosystem of startups and established corporations. The presence of prominent pharmaceutical companies, as well as renowned academic and research institutions, fuels innovation and customer purchasing. This is reflected in the volume of patents issued, which is among the highest globally. EU countries have well-established pharmaceutical industries and sophisticated research institutions that drive the demand for 3D protein structure analysis. The EU's regulatory framework and funding mechanisms such as Horizon Europe encourage collaborative research and innovation in protein analysis. Initiatives such as the Innovative Medicines Initiative (IMI) foster partnerships between key industry players, enhancing investment and adoption of new technologies across the region. The MEA region shows a varied landscape in the 3D protein structure analysis market. While certain countries in the Middle East have advanced healthcare systems with growing investment in research, many African nations are still burgeoning markets with untapped potential. Increased funding from international bodies and collaboration with developed nations for technology transfer can drive growth in these regions. The Asia Pacific region represents a rapidly growing section of the global protein structure analysis market. China's fast-growing biotech sector and heavy government investment in basic research have positioned it as a significant player. Japan remains a technology-intense market with pioneering protein research and high-tech instrumentation techniques, while India is emerging as an attractive market with its expanding biopharmaceutical industry and improving research infrastructure. Despite diverse economic backgrounds, these countries have a common pursuit towards innovation in healthcare and drug development, leading to increased demand for 3D protein analysis solutions.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the 3D Protein Structure Analysis Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the 3D Protein Structure Analysis Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the 3D Protein Structure Analysis Market, highlighting leading vendors and their innovative profiles. These include Agilent Technologies, Inc., Anton Paar GmbH, Arinax Scientific Instrumentation, Bio-Prodict, Bruker Corporation, Cambridge Isotope Laboratories, Inc., CD ComputaBio, Charles River Laboratories, Inc., Corning Incorporated, Creative Proteomics, Dassault Systemes SE, Discngine SAS, DNASTAR, Fujifilm Holdings Corporation, Greiner Bio-One International GmbH, Hampton Research Corporation, Jena Bioscience GmbH, JEOL Ltd., Malvern Panalytical Ltd., Merck KGaA, MiTeGen, LLC, Molecular Dimensions, NanoImaging Services, Promega Corporation, Rigaku Corporation, Saromics Biostructures AB, Schrodinger, Inc., Sygnature Discovery Ltd., and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the 3D Protein Structure Analysis Market to forecast the revenues and analyze trends in each of the following sub-markets:

Component
- Consumable
- Instrument
- Software
Technique
- Cryo Electron Microscopy
- NMR spectroscopy
- X-ray Crystallography
End-User
- Academic & Government Institutes
- Contract Research Organizations
- Pharmaceutical & Biotechnology Companies
Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam
- Europe, Middle East & Africa
  - Denmark
  - Egypt
  - Finland
  - France
  - Germany
  - Israel
  - Italy
  - Netherlands
  - Nigeria
  - Norway
  - Poland
  - Qatar
  - Russia
  - Saudi Arabia
  - South Africa
  - Spain
  - Sweden
  - Switzerland
  - Turkey
  - United Arab Emirates
  - United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the 3D Protein Structure Analysis Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the 3D Protein Structure Analysis Market?

3. What are the technology trends and regulatory frameworks in the 3D Protein Structure Analysis Market?

4. What is the market share of the leading vendors in the 3D Protein Structure Analysis Market?

5. Which modes and strategic moves are suitable for entering the 3D Protein Structure Analysis Market?

Product Code: MRR-2E76C3E47F7B

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

4.1. Introduction
4.2. 3D Protein Structure Analysis Market, by Region

5. Market Insights

5.1. Market Dynamics
- 5.1.1. Drivers
  - 5.1.1.1. Growing scientific awareness about the importance of proteins in disease progression
  - 5.1.1.2. Rise in investment for research and development of drugs
- 5.1.2. Restraints
  - 5.1.2.1. Lack of skilled personnel and difficulty in performing 3d protein structure analysis
- 5.1.3. Opportunities
  - 5.1.3.1. Technological advancements in equipment for 3D protein structure analysis
  - 5.1.3.2. Focus on automation and use of bioinformatics tools in 3D protein structure analysis
- 5.1.4. Challenges
  - 5.1.4.1. Technical limitations in accurately predicting protein structure and interactions
5.2. Market Segmentation Analysis
- 5.2.1. Components: Softwares are highly valued for its user-friendliness, data accuracy, powerful visualization tools, and ongoing support and updates
- 5.2.2. Technology: Cryo-Electron Microscopy is a preferred choice for studying dynamic processes and transient protein structures
- 5.2.3. End-User: 3D protein structure analysis used crucially in pharmaceutical and biotechnology companies for a swift translation of scientific breakthroughs into marketable therapies
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter's Five Forces Analysis
- 5.5.1. Threat of New Entrants
- 5.5.2. Threat of Substitutes
- 5.5.3. Bargaining Power of Customers
- 5.5.4. Bargaining Power of Suppliers
- 5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework

6. 3D Protein Structure Analysis Market, by Component

6.1. Introduction
6.2. Consumable
6.3. Instrument
6.4. Software

7. 3D Protein Structure Analysis Market, by Technique

7.1. Introduction
7.2. Cryo Electron Microscopy
7.3. NMR spectroscopy
7.4. X-ray Crystallography

8. 3D Protein Structure Analysis Market, by End-User

8.1. Introduction
8.2. Academic & Government Institutes
8.3. Contract Research Organizations
8.4. Pharmaceutical & Biotechnology Companies

9. Americas 3D Protein Structure Analysis Market

9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific 3D Protein Structure Analysis Market

10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam

11. Europe, Middle East & Africa 3D Protein Structure Analysis Market

11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom

12. Competitive Landscape

12.1. FPNV Positioning Matrix
12.2. Market Share Analysis, By Key Player
12.3. Competitive Scenario Analysis, By Key Player
- 12.3.1. Merger & Acquisition
  - 12.3.1.1. Thermo Fisher to Acquire Olink for USD 3.1 Billion, Expanding Proteomics Presence
  - 12.3.1.2. Agilent Announces Acquisition of e-MSion, Early-Stage Company Behind ECD Technology that Helps Accelerate Drug Development
- 12.3.2. Agreement, Collaboration, & Partnership
  - 12.3.2.1. GenNext Technologies Announces Partnership with Emery Pharma on Full-Solution Biopharmaceutical Protein Footprinting Services

13. Competitive Portfolio

13.1. Key Company Profiles
- 13.1.1. Agilent Technologies, Inc.
- 13.1.2. Anton Paar GmbH
- 13.1.3. Arinax Scientific Instrumentation
- 13.1.4. Bio-Prodict
- 13.1.5. Bruker Corporation
- 13.1.6. Cambridge Isotope Laboratories, Inc.
- 13.1.7. CD ComputaBio
- 13.1.8. Charles River Laboratories, Inc.
- 13.1.9. Corning Incorporated
- 13.1.10. Creative Proteomics
- 13.1.11. Dassault Systemes SE
- 13.1.12. Discngine SAS
- 13.1.13. DNASTAR
- 13.1.14. Fujifilm Holdings Corporation
- 13.1.15. Greiner Bio-One International GmbH
- 13.1.16. Hampton Research Corporation
- 13.1.17. Jena Bioscience GmbH
- 13.1.18. JEOL Ltd.
- 13.1.19. Malvern Panalytical Ltd.
- 13.1.20. Merck KGaA
- 13.1.21. MiTeGen, LLC
- 13.1.22. Molecular Dimensions
- 13.1.23. NanoImaging Services
- 13.1.24. Promega Corporation
- 13.1.25. Rigaku Corporation
- 13.1.26. Saromics Biostructures AB
- 13.1.27. Schrodinger, Inc.
- 13.1.28. Sygnature Discovery Ltd.
- 13.1.29. Thermo Fisher Scientific Inc.
13.2. Key Product Portfolio

14. Appendix

14.1. Discussion Guide
14.2. License & Pricing